Rockwell Medical Stock Price and Value Analysis

Should you buy Rockwell Medical stock? (NasdaqGM:RMTI). Let's see how it does in our automated value investing analysis system.

RMTI Free Cash Flow Trend

Free Cash Flow trendline for RMTI
Free Cash Flow trendline for Rockwell Medical

Hmm, we can't give any reliable projection for Rockwell Medical's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is solid.
  • This company is not making money.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the RMTI Numbers

RMTI Price
(Rockwell Medical stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - Major stocks
[?] Cash Yield -10.52%
[?] Free Cash Flow Jitter 61%

Is Rockwell Medical Stock on Sale?

Based on our analysis, we believe that you should not buy Rockwell Medical right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy RMTI Stock?

Does Rockwell Medical have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.